STOCKS TELEGRAPH

Author: ST Staff

  • Has Genscript (GNNSF) Stock Increased For A Reason Last Session?

    Has Genscript (GNNSF) Stock Increased For A Reason Last Session?

    Last session, the world’s leading reagents provider GenScript Biotech Corp (OTCPink: GNNSF) closed at $3.48 after seeing a rise of 16.00% that raised its market capitalization to $6.88B. GenScript stock has been trading at a flat $3.48 level. The GNNSF stock price increased when no current news was available, so recent developments may provide more insight about the company.

    How has GNNSF been recently?

    In the global biotech sector, GenScript serves a number of customers. The GNNSF has developed four major platforms leveraging its leading gene synthesis technology, including the global cell therapy platform, the biologics contract development and manufacturing organization (CDMO) platform, the contract research organization (CRO) platform, and the industrial synthesis product platform. More than 100 patents and more than 270 patent applications protect GenScript intellectual property and technology secrets. Approximately 42,000 peer-reviewed journals cited GNNSF’s products and services worldwide as of December 31, 2019.

    Recent company news unveiled that GenScript has started a Research Lentiviral Vector Packaging Service to aid researchers in research on cell lines, gene editing, and drug discovery.

    • With GNNSF’s proprietary platform, scientists can create functional, intact viruses from almost any genetic material of their choice.
    • It is becoming increasingly important to have access to high-quality lentiviruses to discover therapeutics against COVID-19 as well as any new mutant strains of the virus.
    • In the Krogan lab at UCSF’s Quantitative Biosciences Institute (QBI) and the Gladstone Institute of Data Science and Biosciences (GIDB), molecular and systems biologist Dr Nevan Krogan has been using GNNSF’s lentiviruses to identify drugs that can inhibit COVID-19.

    How did QBI’s biologist explain it?

    Krogan said that QBI’s ability to evaluate existing drugs that might be repurposed for fighting COVID-19 faster has been facilitated by direct access to GNNSF’s high-quality, functionally intact titers. QBI would have wasted time and money generating lentiviruses on its own, and if the quality of viral vectors was poor, it would have needed to repeat experiments multiple times, delaying its progress. Because of this reason, QBI plans to provide lentivirus services in the future in cooperation with GenScript (GNNSF).

  • In What Way Did The Draganfly (DFLYF) Stock Price Increase By 16%?

    In What Way Did The Draganfly (DFLYF) Stock Price Increase By 16%?

    After gaining 15.65% last session, award-winning, industry-leading drone solution developer and operator Draganfly Inc. (OTCQB: DFLYF) closed the session at $1.7000 which caused its market cap grew to $116.46M. With a volume of 790.77K shares, Draganfly stock traded less than its typical daily volume of 1.33M shares during the session.

    Additionally, DFLYF stock has been trading between $1.4900 and $1.7400. The pink sheets DFLYF stock has 65.82 million outstanding shares against 26.28 million float. As a result of release of the quarterly results, the DFLYF stock price rose.

    How did DFLYF do?

    A leader in producing top-of-the-line software that revolutionizes the way companies work and serve their stakeholders, Draganfly creates software and systems that are cutting edge. As a technology-leading manufacturer and developer with over 22 years of experience serving the public safety, agricultural, industrial, security, mapping, and surveying markets, DFLYF has won numerous awards and honors.

    Last week, Draganfly released its financial results for the first quarter. As a result of organic growth, DFLYF acquired Dronelogics Systems Inc. and sold COVID-19 screening products during the first quarter.

    Highlights of financial results:

    • Draganfly’s revenue for the first quarter increased 209.8%, from $497,057 in the first quarter of 2020 to $1,539,736 in the first quarter of 2021.
    • Product sales of DFLYF accounted for the bulk of revenue growth.
    • Due to the effects of the pandemic, revenue from the DFLYF’s Engineering Services division has decreased substantially year over year in the first quarter of 2021.
    • Almost all of the DFLYF’s remaining revenues came from drone services sales of $409,963.
    • In Q1 2021, the gross margin percentage was 33.4%, versus 22.2% in Q4 2020.
    • A change in the sales mix explains that increase.
    • With the DFLYF’s traditional custom engineering services which decreased in volume primarily due to COVID-19, gross margin decreased by 62.0% year over year.

    The cash position improved as follows:

    Cash balance held by DFLYF was $21.1 million on March 31, 2021, as opposed to $2.0 million on December 31, 2020. Incorporated by the Company’s Regulation A offering, Draganfly (DFLYF) raised US$16,450,000 million.

  • The NDYN Stock Price Rose 19% On What Basis?

    The NDYN Stock Price Rose 19% On What Basis?

    A healthy gain was recorded on Vinings Holdings Inc. (OTCPK-NDYN) stock as it gained 19.05% to $5.0000 at last close. Last week, Vinings stock scored 25.00% versus 57.48 percent for the month. Technology co-development agreements helped NDYN stock rise.

    What agreements have been made by NDYN?

    Vinings is a biopharmaceutical company that acquires, develops, and commercializes pharmaceutical products in the branded and generic categories. Besides two approved drugs, NDYN has two drugs that are still in the clinical trials stage.

    In addition, to be a holding company, NDYN is also the parent company of Coeptis Pharmaceuticals, Inc. NDYN offers Conjupri (levamlodipine) tablets to treat high blood pressure and Consensi (amlodipine and celecoxib) to treat osteoarthritis pain.

    Earlier this month, Vinings announced that its subsidiary Coeptis Pharmaceuticals, Inc. entered into two separate exclusive option agreements with VyGen Bio.

    • VyGen is the majority-owned subsidiary of Vycellix, Inc.
    • The agreements covered the testing of technologies that may be used to treat cancers linked to CD38.
    • There are two technologies of CD38-GEAR-NK and CD38-Diagnostic were involved in the agreement.
    • CD38-GEAR-NK was created for the purpose of protecting CD38+ natural killer (NK) cells from destruction by monoclonal antibodies (mAbs) against CD38.
    • CD38-Diagnostic, on the other hand, is an in vitro diagnostic tool being developed to determine whether a cancer patient is a candidate for anti-CD38 mAb therapy.
    • Researchers at the Karolinska Institutet in Sweden discovered the Gene-Edited Antibody Resistant NK Platform (GEAR-NK), which VyGen-Bio is using to advance both the therapeutics.

    Have any agreements been reached?

    Specifically, Coeptis purchased the exclusive option to use the Vinings (NDYN)’s CD38-GEAR-NK technology from VyGen-Bio for a non-refundable fee. In regards to the second option, VyGen-Bio received a non-refundable fee from NDYN’s Coeptis for the exclusive option to sell the CD38-Diagnostic technology to Coeptis.

  • How Did Foraco (FRACF) Stock Gain 32%?

    How Did Foraco (FRACF) Stock Gain 32%?

    After seeing a rise of 17.28%, leading global provider of mineral drilling services, Foraco International SA (OTCPk: FRACF) closed its last session at $1.4249, bringing its market capitalization to $128.17M.

    Foraco stock traded 840 shares, below its average daily volume of 5.73K with 89.95M shares outstanding. An upcoming refinancing proposal has contributed to the increase in the FRACF stock.

    The proposed refinancing was for what?

    Foraco is a leading drilling services company that provides a range of turnkey solutions for engineering, mining, and energy projects. Integrity, innovation, and involvement are at the core of the company, so FRACF is now the 3rd largest global drilling company with operations in 22 countries across five continents.

    A binding term sheet to reorganize Foraco’s existing indebtedness has been signed this month.

    • In effecting an early redemption of Foraco’s existing bonds, the Financial Reorganization will significantly improve the FRACF’s debt profile.
    • A new bonds facility was entered into by FRACF and Marathon Asset Management LP (“Marathon”).
    • Upon completion of the Financial Reorganization, net debt is expected to decrease by approximately US $49.4 million.
    • As part of the Term Sheet, Marathon and FRACF agreed to establish US $100 million senior secured debt.
    • FRACF will close the Senior Bonds Facility on or around June 30, 2021.
    • A maturity date of December 15, 2025, has been set for the Senior Bonds Facility.
    • As part of the Term Loan, the first 5 million dollars will be repaid on the first anniversary of the Closing Date, 10 million dollars on the second, third, and fourth anniversaries, and the remaining amount on the maturity date.

    Foraco’s refinancing plan: how will it work?

    FRACF may choose to repay accrued interest every three months or every six months. Foraco (FRACF) and certain of its subsidiaries will grant security interests in certain of their material assets in connection with the Senior Bonds Facility.

  • YUKA Stock Rose 27%. What Led To That?

    YUKA Stock Rose 27%. What Led To That?

    At the close of Friday session, Yuka Group Inc. (OTCPink: YUKA) was up 26.89% at $1.6750. Volume of Yuka stock was 15.9K, compared with its Average Weekly Volume of 6.24K. Since YUKA stock rose in spite of current news, we can point to recent developments to get a better understanding of YUKA.

    How did YUKA do recently?

    Yuka, an e-commerce company, helps brands get access to strategic sales channels for entering the global market or expanding there. YUKAs brand building and marketing services can help clients expand their brand’s reach. YUKA offers more than just comprehensive sales and marketing services; they also offer operational logistics, product and brand photography, and product and marketing research.

    Last month, Yuka announced that it had hired a PCAOB independent accountant and a law firm to perform a two-year audit, which will be followed by a Form 10 filing to the Securities and Exchange Commission (SEC).

    As a result of its successful collaboration with two advisors, Yuka Group is looking forward to filing Form 10 which enables its shareholders and investors to better understand the company’s common stock, said Meir Avitan, Yuka Group’s CEO and Board Member. YUKA achieved a significant milestone through this filing. Investors gain complete transparency and the value of the shares increases.

    Yuka’s plans going forward:

    YUKA has committed to completing the 2-year audit within the next 4 months as well as filing the Form 10 Statement. YUKA will also provide periodic updates regarding upcoming acquisitions and company news.

  • What Explained WikiSoft (WSFT) Stock 25% Gain?

    What Explained WikiSoft (WSFT) Stock 25% Gain?

    In the last session, WikiSoft Corp (OTCPINK: WSFT) closed at $1.9900, up 25.16 percent. WikiSoft stock priced between $1.5000 and $1.9900 during the session, while 1.75K shares were traded. Following the launch of its next-generation business networking platform, WSFT stock rose.

    Which platform was that?

    WikiSoft is in view that the development of globalization has resulted in an increased demand for reliable information about companies and employees worldwide. Wikiprofile.com, WikiSoft’s flagship online platform, is designed to provide businesses and professionals with tools and resources. The vision of WSFT is to facilitate global career and hiring decisions for businesses and individuals.

    The next version of their flagship platform Wikiprofile.com will be released on June 1st, announced WikiSoft last week.

    Millions of companies and business professionals are represented in the beta version. There are many features and functionalities available in the new beta version including but not limited to:

    • A modern networking platform that helps companies form stronger relationships with professionals
    • A simple registration process that allows anyone to sign up
    • Ability to find companies and professionals for free
    • A quick search engine with filters to find the right information
    • Users of Wikiprofile can easily locate great companies and people at any time.

    Using advanced algorithms and user reviews, the Wikiteam helps ensure the validity of Wiki content by focusing on credibility, trust, and ethics. During the first months of the year, WikiSoft has already achieved several milestones that are beneficial to investors and shareholders.

     How will the platform help?

    The launch of the beta version of Wikiprofile.com is a significant milestone for WikiSoft (WSFT). Powered by tools and resources, the WSFT platform was created with an aim to empower businesses and business professionals to make informed career and hiring decisions.

  • Is There Any Reason As To Why The Bimini (BMNM) Stock Expanded By 20%?

    Is There Any Reason As To Why The Bimini (BMNM) Stock Expanded By 20%?

    Stock of Bimini Capital Management, Inc. [OTCQB: BMNM] surged 20.44% to $1.6500 at the previous close. The volume of Bimini stock was 28.21K, compared to its 30-day average of 7.41K. In the last 52 weeks, price of BMNM stock varied between $0.4200 and $1.7400. BMNM stock rose after the tender offer was launched.

    In what manner was BMNM planning to acquire shares?

    In addition to investing in residential mortgage-related securities issued by the Federal National Mortgage Association (Fannie Mae), the Federal Home Loan Mortgage Corporation (Freddie Mac) and the Government National Mortgage Association (Ginnie Mae), Bimini Capital Management also invests in the municipal and commercial mortgage markets. According to BMNM, it seeks to earn returns from the spread between its assets and its costs, which include interest expense associated with borrowing funds.

    As of last week, Bimini announced the initiation of an “advanced Dutch auction” tender offer.

    • Shares of class A common stock with a par value of $0.001 each will be purchased by BMNM to the tune of up to $2.2 million.
    • Similarly, fewer shares may be considered if properly tendered and not withdrawn, for a price not to exceed $2.00 nor less than $1.50 per share of Class A Common Stock, without tax withholdings and without interest (the “Offer”).
    • It is not necessary to tender a minimum number of Class A Common Stock shares to be eligible to participate in the BMNM offer.

    The offer will be executed in what way?

    Bimini (BMNM)’s Offer to Purchase and related Letter of Transmittal describing BMNM’s Offer to Purchase are filed with the SEC on May 27, 2021, on the terms outlined in the offers. The letters will also be sent to designated brokers or other nominees of holders of Class A Common Stock, as appropriate.

  • How Did The Boral (BOALF) Stock Skyrocket In The Last Session, Jumping 119%?

    Boral Ltd (OTCPink: BOALF) closed at $5.0000 on Thursday, up 119.30 percent, and is trading at a range between $5.00 and $5.50. At a monthly average volume of 4.93K shares, Boral stock has spiked over 7.53% in the past 30 days. Recent tender offers of its subsidiary helped BOALF stock rise.

    The offer was for what?

    As an international building products and construction materials group founded in 1946, Boral operates two divisions: an integrated construction materials business in Australia, and a fly ash and building products business in North America. Globally, BOALF employs more than 17,000 employees and contractors across 650 operating and distribution facilities.

    Earlier in May 2021, Boral Finance Pty Ltd, a wholly-owned subsidiary of Boral Limited, announced it had started a tender opportunity to buy any and all of its outstanding 3.000% Guaranteed Senior Notes due 2022 for cash.

    As part of the Tender Offer, Boral provided a detailed description of what the Tender Offer is, as well as a notice of guaranteed delivery. The Offer to Purchase was dated May 17, 2021.

    BOALF announced last week that the deadline for submitting bids for the Tender Offer was 5:00 pm, May 21st, 2021.

    Financial aspects of the offering:

    D.F. King & Co. Inc was the tender and information agent for the Tender Offer. As of the expiration of the tender offer, $323,063,000 in aggregate principal amount of the Notes were validly tendered and not validly withdrawn, reported the agent. The offer to purchase Boral (BOALF)’s Notes included US$100,000 principal amount of notes that have been tendered in accordance with the BOALF’s guaranteed delivery provision.

  • Is This Why The Adyen (ADYYF) Stock Took A Dip Last Session?

    Stock of the global payments platform of choice for many of the world’s leading companies, Adyen N.V. (OTCPk: ADYYF) closed Thursday at $2319.6 after dipping -0.87 percent. Adyen stock rose 94.29% in the past year, hitting a high of $2738.4 that brought its market cap to $68.65 billion. ADYYF stock rose after expanding its acquiring capabilities.

    How has the ADYYF expanded its capabilities?

    Many of the world’s leading companies use Adyen’s payments platform. The Adyen platform fits seamlessly into Visa, MasterCard, and consumer-preferred payment methods worldwide. Through online, mobile, and in-store channels, ADYYF offers frictionless payments. ADYYF customers include Facebook, Uber, Spotify, Casper, Bonobos, and L’Oréal, and it has offices in countries around the world.

    Adyen recently pitched an idea of expanding its acquiring abilities to include Japan. By providing local payments for merchants such as Microsoft, Foodpanda, VanMoof, Breitling, and G-Star, ADYYF’s acquiring capabilities form the foundation of the company’s all-in-one payment platform.

    Following ADYYF’s announcements in Australia, New Zealand, Hong Kong, Malaysia, and Singapore, this announcement expands the company’s local acquiring capabilities in Asia-Pacific. ADYYF wanted to better serve Japanese shoppers by extending its acquiring service capabilities as a result of demand from international and domestic merchants.

    What sets ADYYF apart?

    As a payment gateway, risk management, and acquirer, Adyen (ADYYF) takes care of the entire payment flow for its merchants. Therefore, ADYYF brands will be able to expand globally and optimize payment processes while maintaining customer satisfaction.

  • What Led The AYRWF Stock To Increase 3% Past Trading?

    What Led The AYRWF Stock To Increase 3% Past Trading?

    Ayr Wellness Inc (OTCQX: AYRWF), a vertically-integrated cannabis multi-state operator (MSO), closed the last trading session at $30.816 with a gain of 3.22% that brought its market cap to $1.47B. Ayr stock has been trading in a range from $29.900 to $31.870 with 47.81M shares outstanding.  In response to its financial results, AYRWF stock rose.

    AYRWF’s performance in the reported quarter:

    As an expanding vertically integrated, multistate cannabis provider in the U.S., Ayr is committed to delivering the highest quality cannabis products and services to its clients. The AYRWF team is dedicated to growing superior branded cannabis products based on the belief that everything starts with quality. Through wellness and wonder, AYRWF strives to enhance the consumer’s experience every day.

    A quarterly financial report has been published by Ayr yesterday for the three months ended March 31, 2021.

    Financial Highlights:

    • As of Q1, AYRWF reported $58.4 million in revenue, an increase of 74% from that in the same quarter a year ago.
    • Adjusted EBITDA for AYRWF was $20.0 million on IFRS basis which decreased to $18.4 million when accounted on the basis of US GAAP, and that represents an increase of 136% year-over-year.
    • AYRWF reported an operating loss of $8.4 million, including $26.5 million in non-cash and one-time expenses.

    What else has AYRWF accomplished?

    • With the acquisition of Liberty Health Sciences, Ayr Wellness (AYRWF) added 42 retail dispensaries to its footprint in Florida, making it the fourth largest in the state.
    • AYRWF closed its acquisitions in Arizona and Ohio, which brought its footprint to 6 of the U.S. states while those in 7th state of New Jersey are expected to concluded by this summer.
    • AYRWF expects to generate approximately $90 million in revenue in 2Q21.
    • The Revenue estimate was up 218% year over year and 54% quarter over quarter, with Adjusted EBITDA margins between 30% and 40%.